NasdaqGS:RXRXBiotechs
Assessing Recursion Pharmaceuticals (RXRX) After A 51% One Year Share Price Decline
If you are wondering whether Recursion Pharmaceuticals' current share price makes sense, the key question is how that price compares with what the business could reasonably be worth.
The stock last closed at US$3.67, with a 7 day return of 7.3%, a 30 day return decline of 12.4%, a year to date return decline of 12.6%, and a 1 year return decline of 51.1%. These figures will shape how many investors think about its potential and risk today.
Recent coverage has focused on Recursion...